Search research articles
Contact Us
Filters
Showing results (81-90 of 515) with videos related to
Page
of 52
Sort By:
Endocrine Research Communications
|
January 1, 1977
Purification of the gonadotropin-releasing hormone-degrading enzyme by affinity chromatography
Y Koch, T Baram, E Hazum, et al.
Journal of Biological Response Modifiers
|
December 1, 1987
Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanisms
S Dagan, E Tzehoval, M Fridkin, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
December 14, 2011
Homogeneous switching in ultrathin ferroelectric films
R Gaynutdinov, S Yudin, S Ducharme, et al.
Mini Reviews in Medicinal Chemistry
|
February 7, 2012
From antioxidant chelators to site-activated multi-target chelators targeting hypoxia inducing factor, beta-amyloid, acetylcholinesterase and monoamine oxidase A/B
H Zheng, M Fridkin, M B H Youdim
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1986
Analysis of ligand binding to the synthetic dodecapeptide 185-196 of the acetylcholine receptor alpha subunit
D Neumann, D Barchan, M Fridkin, et al.
Biochimica Et Biophysica Acta
|
January 24, 1977
Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes
M Fridkin, Y Stabinsky, V Zakuth, et al.
International Journal of Peptide and Protein Research
|
September 1, 1978
Synthesis and biological activity of tuftsin and of [O = C Thr1]-tuftsin. A novel synthetic route to peptides containing N-terminal L -O = C Thr and L - O = C Ser residues
Y Stabinsky, M Fridkin, V Zakuth, et al.
Neurochemical Research
|
October 29, 2010
Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease
Hailin Zheng, Mati Fridkin, Moussa B H Youdim
ACS Chemical Biology
|
May 12, 2010
Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy
Hailin Zheng, Moussa B H Youdim, Mati Fridkin
International Journal of Peptide and Protein Research
|
January 1, 1977
A photolabile protecting group for the phenolic hydroxyl function of tyrosine
B Amit, E Hazum, M Fridkin, et al.
Page
of 52
Search research articles
Search
Showing results (81-90 of 515) with videos related to
Sort By:
Page
of 52
Endocrine Research Communications
|
January 1, 1977
Purification of the gonadotropin-releasing hormone-degrading enzyme by affinity chromatography
Y Koch, T Baram, E Hazum, et al.
Journal of Biological Response Modifiers
|
December 1, 1987
Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanisms
S Dagan, E Tzehoval, M Fridkin, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
December 14, 2011
Homogeneous switching in ultrathin ferroelectric films
R Gaynutdinov, S Yudin, S Ducharme, et al.
Mini Reviews in Medicinal Chemistry
|
February 7, 2012
From antioxidant chelators to site-activated multi-target chelators targeting hypoxia inducing factor, beta-amyloid, acetylcholinesterase and monoamine oxidase A/B
H Zheng, M Fridkin, M B H Youdim
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1986
Analysis of ligand binding to the synthetic dodecapeptide 185-196 of the acetylcholine receptor alpha subunit
D Neumann, D Barchan, M Fridkin, et al.
Biochimica Et Biophysica Acta
|
January 24, 1977
Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes
M Fridkin, Y Stabinsky, V Zakuth, et al.
International Journal of Peptide and Protein Research
|
September 1, 1978
Synthesis and biological activity of tuftsin and of [O = C Thr1]-tuftsin. A novel synthetic route to peptides containing N-terminal L -O = C Thr and L - O = C Ser residues
Y Stabinsky, M Fridkin, V Zakuth, et al.
Neurochemical Research
|
October 29, 2010
Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease
Hailin Zheng, Mati Fridkin, Moussa B H Youdim
ACS Chemical Biology
|
May 12, 2010
Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy
Hailin Zheng, Moussa B H Youdim, Mati Fridkin
International Journal of Peptide and Protein Research
|
January 1, 1977
A photolabile protecting group for the phenolic hydroxyl function of tyrosine
B Amit, E Hazum, M Fridkin, et al.
Page
of 52